Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective
Leukemia
,
Oncology
Novel Agents Will Completely Change CLL Treatment
Read More
Leukemia
,
Oncology
Bendamustine Outperforms R-CHOP in NHL
Read More
Pediatric Cancer
,
Oncology
Crizotinib Effective in Aggressive Pediatric Tumors
Caroline Helwick
Read More
FDA Approvals
The Oncology Drug Pipeline Robust with Novel Agents
Caroline Helwick
,
Wayne Kuznar
Read More
Perspectives
Payers Collaborate with Providers to Adopt Oncology Pathways, New Care Delivery Models
Rhonda Greenapple, MSPH
Read More
Family History of Cancer/Genetic Counseling Often Lacking for Patients First Presenting with Malignancy
Wayne Kuznar
Read More
For Advanced GIST, Regorafenib Shows Robust Effect
Read More
Cancer Screening Is Cost-Effective, Saves Lives
Read More
Cancer Therapies in Short Supply Prompt a Response at the Federal Level
Wayne Kuznar
Read More
High OOP Costs for Medicare Patients with Cancer
Mark Knight
Read More
1
2
3
4
Page 2 of 4
Results 11 - 20 of 33
